Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

Improving Design, Evaluation and Analysis of early drug development Studies

De 2015-01-01 à 2018-12-31, projet en cours

Détails concernant le projet

Coût total:

EUR 3 108 939,48

Contribution de l'UE:

EUR 3 108 939,48

Coordonné à/au(x)/en:

United Kingdom

Appel à propositions:

H2020-MSCA-ITN-2014See other projects for this call

Régime de financement:

MSCA-ITN-ETN - European Training Networks

Objectif

Coordinateur

LANCASTER UNIVERSITY
United Kingdom

Contribution de l'UE: EUR 819 863,64


BAILRIGG
LA1 4YW LANCASTER
United Kingdom
Activity type: Higher or Secondary Education Establishments

Participants

MEDIZINISCHE UNIVERSITAET WIEN
Austria

Contribution de l'UE: EUR 511 868,16


SPITALGASSE 23
1090 WIEN
Austria
Activity type: Higher or Secondary Education Establishments
POLITECNICO DI TORINO
Italy

Contribution de l'UE: EUR 516 122,64


CORSO DUCA DEGLI ABRUZZI 24
10129 TORINO
Italy
Activity type: Higher or Secondary Education Establishments
INSTITUT CURIE
Fin de participation
France

Contribution de l'UE: EUR 0


rue d'Ulm 26
75231 PARIS
France
Activity type: Research Organisations
Bayer Pharma AG
Germany

Contribution de l'UE: EUR 249 216,48


Muellerstr.
D-13353 Berlin
Germany
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
UNIVERSITAET BREMEN
Germany

Contribution de l'UE: EUR 498 432,96


Bibliothekstrasse 1
28359 BREMEN
Germany
Activity type: Higher or Secondary Education Establishments
JANSSEN PHARMACEUTICA NV
Belgium

Contribution de l'UE: EUR 250 560


Turnhoutseweg
2340 Beerse
Belgium
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France

Contribution de l'UE: EUR 262 875,60


RUE DE TOLBIAC 101
75654 PARIS
France
Activity type: Research Organisations
Numéro d'enregistrement: 193243 / Dernière mise à jour le: 2016-06-20